Hoai-thu Thai
Sanofi R&D
Chilly, France
Chilly, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Novel Drug-Disease Modeling Framework for Oncology Benefit-Risk Evaluation: Application to Tusamitamab Ravtansine.
Journal: CPT: pharmacometrics & systems pharmacology
Published: July 11, 2025
Isatuximab-dexamethasone-pomalidomide combination effects on serum M protein and PFS in myeloma: Development of a joint model using phase I/II data.
Journal: CPT: pharmacometrics & systems pharmacology
Published: January 31, 2024
Joint modeling of tumor dynamics and progression-free survival in advanced breast cancer: Leveraging data from amcenestrant early phase I-II trials.
Journal: CPT: pharmacometrics & systems pharmacology
Published: September 21, 2023
Model-based simulation to support the approval of isatuximab alone or with dexamethasone for the treatment of relapsed/refractory multiple myeloma in Japanese patients.
Journal: CPT: pharmacometrics & systems pharmacology
Published: September 30, 2022
Exposure-response analyses for selection/confirmation of optimal isatuximab dosing regimen in combination with pomalidomide/dexamethasone treatment in patients with multiple myeloma.
Journal: CPT: pharmacometrics & systems pharmacology
Published: November 24, 2021
Joint modelling and simulation of M-protein dynamics and progression-free survival for alternative isatuximab dosing with pomalidomide/dexamethasone.
Journal: British journal of clinical pharmacology
Published: July 21, 2021
PK/PD modeling analysis for dosing regimen selection of isatuximab as single agent and in combination therapy in patients with multiple myeloma.
Journal: CPT: pharmacometrics & systems pharmacology
Published: February 12, 2021
Optimizing pharmacokinetic bridging studies in paediatric oncology using physiologically-based pharmacokinetic modelling: application to docetaxel.
Journal: British journal of clinical pharmacology
Published: July 24, 2014
Evaluation of bootstrap methods for estimating uncertainty of parameters in nonlinear mixed-effects models: a simulation study in population pharmacokinetics.
Journal: Journal of pharmacokinetics and pharmacodynamics
Published: April 10, 2013
Population pharmacokinetic analysis of free and bound aflibercept in patients with advanced solid tumors.
Journal: Cancer chemotherapy and pharmacology
Published: March 13, 2013
A comparison of bootstrap approaches for estimating uncertainty of parameters in linear mixed-effects models.
Journal: Pharmaceutical statistics
Published: January 19, 2012
Last Updated: 09/26/2026